Prognosis: Breakthrough

A New Vaccine Frontrunner

Prognosis: Breakthrough

As competitors publicly entered the race to produce a vaccine, drug giant Merck stayed quiet about its development plans. Now, the company has revealed it’s working on two vaccines and a treatment pill -- emerging as a frontrunner in the development contest. Although the company has refused to give firm timelines for its research, it has pledged to make its vaccines and pill available globally, if they're successful. Riley Griffin talked with Merck Chief Executive Kenneth C. Frazier about the company's plans. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Next Episodes

Prognosis: Breakthrough

How Many People Have Really Died? @ Prognosis: Breakthrough

📆 2020-05-27 22:33 / 00:16:05


Prognosis: Breakthrough

Virus Hunting With the 'Pirate CDC' @ Prognosis: Breakthrough

📆 2020-05-26 23:10 / 00:17:33


Prognosis: Breakthrough

The Home Run Approach @ Prognosis: Breakthrough

📆 2020-05-25 10:00 / 00:12:15


Prognosis: Breakthrough

Curing Social Distance Fatigue @ Prognosis: Breakthrough

📆 2020-05-22 22:56 / 00:15:10


Prognosis: Breakthrough

The Dire Situation at U.S. Prisons @ Prognosis: Breakthrough

📆 2020-05-21 22:22 / 00:18:52